Clinical Trials Browser

Interventional × EC regimen × Breast × Clear all

NCT02527746 2024-02-23

Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 1 Completed

18 enrolled 22 charts

Breast Neoplasms, Neutropenia

NCT03609047 2024-01-24

Appalaches

Phase 2 Active not recruiting

Breast Neoplasms

NCT05834582 2023-04-28

Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast Cancer

Phase 2 Recruiting

Triple Negative Breast Neoplasms

NCT01210768 2021-11-23

A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms

NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Phase 1 Completed

BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT00567554 2016-02-10

GeparQuinto

Phase 3 Completed

Breast Neoplasms

NCT01204437 2016-02-10

ICE-II

Phase 2/3 Completed

Breast Neoplasms

NCT01199432 2015-06-10

Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer

Phase 4 Completed

Breast Neoplasms

NCT01917578 2013-08-06

BCSMANC

Phase 3 Unknown

Breast Neoplasms

NCT00544505 2011-12-13

Pre-operative Chemotherapy in Operable Breast Cancer, Phase III Study Comparing a Short Intensive Pre-operative Chemotherapy With the Same Therapy Initiated Shortly After Surgery(Peri-operatively)(POCOB)EORTC 10902)

Phase NA Unknown

Breast Neoplasms